MA04.05 Patient-Reported Outcomes With Perioperative Nivolumab by Nodal Status in Patients With Resectable NSCLC From Checkmate 77T
Year: 2025
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: J.D. Spicer, M. Provencio Pulla, T. Cascone, M.M. Awad, L.B. Petruzelka, H. Ito, T.-E. Ciuleanu, L. de Oliveira Muniz Koch, F. Guisier, N. Frost, T.J.N. Hiltermann, S. Lu, S. Bhatia, S.I. Blum, S. Lucherini, R. Lawrance, C. Yip, G. Worthy, C. Coronado Erdmann, F. Tanaka
Institutions: McGill University Health Centre, Hospital Universitario Puerta de Hierro Majadahonda, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Charles University, Kanagawa Cancer Center, Iuliu Hațieganu University of Medicine and Pharmacy, Institute of Oncology Prof. Dr. Ion Chiricuta, Hospital Israelita Albert Einstein, Centre Hospitalier Universitaire de Rouen, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, University Medical Center Groningen, University of Groningen, Shanghai Jiao Tong University, Shanghai Chest Hospital, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (United Kingdom), Adelphi Group (United Kingdom), University of Occupational and Environmental Health Japan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415519531
Cites:
Cited by:
Related to: